Lilly's Taltz and Zepbound combo shows broader biomarker changes
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/9/2026
- Wall Street set for weekly gains with earnings, inflation data on tap
- Oil falls as Trump comments on Iran talks ease supply fears
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
| Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 1174.09 +4.49 (0.38%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1169.60 | 52 Week High | $88.16 | |||
| Open | $1153.56 | 52 Week Low | $67.88 | |||
| Day High | $1179.82 | P/E | 271.78 | |||
| Day Low | $1151.67 | EPS | $4.32 | |||
| Volume | 842,642 | |||||
